Wells Fargo & Company Nexalin Technology, Inc. Transaction History

Wells Fargo & Company

  • $410 Billion
  • Q1 2024

A detailed history of Wells Fargo & Company transactions in Nexalin Technology, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 44 shares of NXL stock, worth $56. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44
Previous 43 2.33%
Holding current value
$56
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$0.3 - $1.4 $0 - $1
1 Added 2.33%
44 $0
Q4 2023

Feb 09, 2024
BUY
$0.28 - $0.52 $0 - $0
1 Added 2.38%
43 $0
Q3 2023

Nov 13, 2023
BUY
$0.38 - $0.95 $9 - $23
25 Added 147.06%
42 $0
Q2 2023

Aug 15, 2023
BUY
$0.72 - $0.92 $0 - $0
1 Added 6.25%
17 $0
Q4 2022

Feb 13, 2023
BUY
$0.74 - $2.39 $11 - $38
16 New
16 $0

Others Institutions Holding NXL

# of Institutions
6
Shares Held
63.5K
Call Options Held
0
Put Options Held
0
View Full List

About Nexalin Technology, Inc.

NXL Quotes by TradingView
  • Ticker NXL
  • Exchange
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 7,279,960
  • Market Cap $9.39M
More about NXL
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email